Related Experiment Video

Updated: May 6, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

9.9K

Pathophysiology and clinical aspects of hypertensive hypertrophy

M Vogt1, W H Motz, B Schwartzkopf

  • 1Abteilung für Kardiologie, Heinrich-Heine-Universität Dusseldorf, Germany.

European Heart Journal
|July 1, 1993
PubMed

Insights

Individuals with hypertension and left ventricular hypertrophy (LVH) face a tenfold higher risk of cardiac failure. Treating hypertensive heart disease aims to reverse LVH and improve coronary artery function for better outcomes.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Cardiac Physiology

Background:

  • Arterial hypertension with left ventricular hypertrophy (LVH) significantly increases cardiac failure risk (10-fold).
  • Hypertensive LVH involves myocardial fibrosis and small intramural artery structural changes.
  • Hypertension, with or without LVH, impairs coronary vasodilator reserve due to small artery disease.

Purpose of the Study:

  • To investigate the treatment goals for hypertensive heart disease.
  • To explore strategies for reversing myocardial hypertrophy and preventing heart failure.
  • To assess methods for improving coronary reserve by addressing small coronary artery disease.

Main Methods:

  • Review of existing literature on hypertension, LVH, and cardiac complications.
  • Analysis of treatment approaches for hypertensive heart disease.
  • Evaluation of pharmacological interventions for LVH and coronary artery function.

Main Results:

  • Hypertensive heart disease prognosis is primarily dictated by cardiac complications.
  • Regression of LVH is achievable with dihydropyridine calcium channel blockers, ACE inhibitors, and sympatholytic agents.
  • Clinical evidence for reversing small coronary artery disease in hypertensives remains limited.

Conclusions:

  • Reversing LVH is crucial for preventing hypertensive heart failure progression.
  • Improving coronary reserve by treating small artery disease is a key therapeutic goal.
  • Further research is needed to establish effective treatments for hypertensive small coronary artery disease.

More Related Videos

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats07:31

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

9.8K
An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

6.6K

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
5.1K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.3K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
891
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy:...
78